Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Fabrice Tirode | Researchclopedia

Back to researchers

Fabrice Tirode

Sanofi (France)

5

Works

71

Citations

1

h-index

1

i10-index

Research Topics

CAR-T cell therapy research Bone health and osteoporosis research Cancer Immunotherapy and Biomarkers

Affiliations

Sanofi (France)1999–2026

Top Works

The visualization and evaluation of bone architecture in the rat using three-dimensional X-Ray microcomputed tomography

A. Barbier,Catherine Martel,et al.

199971 citations

Lipoproteins and Cardiovascular Health

Memory and Neural Mechanisms

Supplementary Figure S4 from TPP-45142—an Anti-HER2 T-cell Engager—Designed for Selective HER2-Low Cancer Immunotherapy

Evelyn De Tavernier,Peter S. Kim,et al.

20260 citations

Supplementary Table S5 from TPP-45142—an Anti-HER2 T-cell Engager—Designed for Selective HER2-Low Cancer Immunotherapy

Evelyn De Tavernier,Peter S. Kim,et al.

20260 citations

Supplementary Table S11 from TPP-45142—an Anti-HER2 T-cell Engager—Designed for Selective HER2-Low Cancer Immunotherapy

Evelyn De Tavernier,Peter S. Kim,et al.

20260 citations

TPP-45142—an Anti-HER2 T-cell Engager—Designed for Selective HER2-Low Cancer Immunotherapy

Evelyn De Tavernier,Peter S. Kim,et al.

20260 citations

Supplementary Table S3 from TPP-45142—an Anti-HER2 T-cell Engager—Designed for Selective HER2-Low Cancer Immunotherapy

Evelyn De Tavernier,Peter S. Kim,et al.

20260 citations

Supplementary Table S4 from TPP-45142—an Anti-HER2 T-cell Engager—Designed for Selective HER2-Low Cancer Immunotherapy

Evelyn De Tavernier,Peter S. Kim,et al.

20260 citations

Supplementary Figure S6 from TPP-45142—an Anti-HER2 T-cell Engager—Designed for Selective HER2-Low Cancer Immunotherapy

Evelyn De Tavernier,Peter S. Kim,et al.

20260 citations

Supplementary Data S1 from TPP-45142—an Anti-HER2 T-cell Engager—Designed for Selective HER2-Low Cancer Immunotherapy

Evelyn De Tavernier,Peter S. Kim,et al.

20260 citations